Everlaw, the cloud-native investigation and litigation platform, today announced its partnership with Array, a leading litigation support firm. Through the collaboration, Array will incorporate ...
When it comes to buying an experienced cancer drug specialist, a bidding war is naturally expected. But in the case of Pfizer’s $11 billion deal for Array BioPharma, that didn’t happen. Still, it didn ...
Zacks.com on MSN
Array Technologies, Inc. (ARRY) Stock Declines While Market Improves: Some Information for Investors
Array Technologies, Inc. (ARRY) closed at $7.00 in the latest trading session, marking a -2.23% move from the prior day. The stock trailed the S&P 500, which registered a daily gain of 1.02%.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results